Publications by authors named "Ryan Montano"

Claim this Profile
C
Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor.
Ryan Montano, Nadeem Khan, Huagang Hou, John Seigne, Marc S Ernstoff

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
Nandini Sakurikar, Ruth Thompson, Ryan Montano, Alan Eastman

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring oxygen levels in orthotopic human glioma xenograft following carbogen inhalation and chemotherapy by implantable resonator-based oximetry.
Huagang Hou, Venkata Krishnamurthy Nemani, Gaixin Du, Ryan Montano, Rui Song

Int J Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo.
Ryan Montano, Ruth Thompson, Injae Chung, Huagang Hou, Nadeem Khan

BMC Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Mre11 nuclease is critical for the sensitivity of cells to Chk1 inhibition.
Ruth Thompson, Ryan Montano, Alan Eastman

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.
Ryan Montano, Injae Chung, Kristen M Garner, David Parry, Alan Eastman

Mol Cancer Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis